{"entity":{"type":"insider","cik":"0001360928","url":"/insider/0001360928","json_url":"/insider/0001360928.json","name":"Sabella Lauren M","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":20,"n_filings":19,"first":"2010-12-03","last":"2019-12-04","span_basis":"filed_date"},"name_variants":[{"name":"Sabella Lauren M","source":"filing","n_filings":19,"first_seen":"2010-12-03","last_seen":"2019-12-04"}],"transactions":[{"id":8011199,"accession":"0001209191-19-058938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-058938","line_url":"/filing/0001209191-19-058938#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1513.0,"shares_display":"1,513","price_per_share":1.6002,"price_display":"1.60","price_state":"stated","total_value":2421.1026,"total_display":"2,421.10","total_whole":"2,421","shares_owned_after":12624.0,"shares_owned_after_display":"12,624","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-02","filed_date":"2019-12-04","scope":"insider"},{"id":8342840,"accession":"0001209191-19-012975","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-012975","line_url":"/filing/0001209191-19-012975#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":761.0,"shares_display":"761","price_per_share":13.1777,"price_display":"13.18","price_state":"stated","total_value":10028.2297,"total_display":"10,028.23","total_whole":"10,028","shares_owned_after":5092.0,"shares_owned_after_display":"5,092","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-22","filed_date":"2019-02-25","scope":"insider"},{"id":6870091,"accession":"0001209191-18-061113","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-061113","line_url":"/filing/0001209191-18-061113","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5191.0,"shares_display":"5,191","price_per_share":20.561840628010017,"price_display":"20.56","price_state":"stated","total_value":106736.5147,"total_display":"106,736.51","total_whole":"106,737","shares_owned_after":1568.0,"shares_owned_after_display":"1,568","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-12-03","filed_date":"2018-12-06","scope":"insider","n_lines":2},{"id":9270754,"accession":"0001209191-18-063965","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-063965","line_url":"/filing/0001209191-18-063965#line-1","is_derivative":false,"issuer_cik":"0001360928","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001360928","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3774.0,"shares_display":"3,774","price_per_share":27.84,"price_display":"27.84","price_state":"stated","total_value":105068.16,"total_display":"105,068.16","total_whole":"105,068","shares_owned_after":7391.0,"shares_owned_after_display":"7,391","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-28","filed_date":"2018-12-21","scope":"insider"},{"id":6473945,"accession":"0001209191-18-040132","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-040132","line_url":"/filing/0001209191-18-040132#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":5859.0,"shares_display":"5,859","price_per_share":27.8443,"price_display":"27.84","price_state":"stated","total_value":163139.7537,"total_display":"163,139.75","total_whole":"163,140","shares_owned_after":5306.0,"shares_owned_after_display":"5,306","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-28","filed_date":"2018-07-02","scope":"insider"},{"id":6046775,"accession":"0001209191-18-037138","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-18-037138","line_url":"/filing/0001209191-18-037138#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24375.0,"shares_display":"24,375","price_per_share":35.0,"price_display":"35.00","price_state":"stated","total_value":853125.0,"total_display":"853,125.00","total_whole":"853,125","shares_owned_after":11165.0,"shares_owned_after_display":"11,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-06-08","filed_date":"2018-06-12","scope":"insider"},{"id":6725608,"accession":"0001209191-18-032315","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-18-032315","line_url":"/filing/0001209191-18-032315#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7288.0,"shares_display":"7,288","price_per_share":23.665,"price_display":"23.66","price_state":"stated","total_value":172470.52,"total_display":"172,470.52","total_whole":"172,471","shares_owned_after":11165.0,"shares_owned_after_display":"11,165","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-05-18","filed_date":"2018-05-22","scope":"insider"},{"id":5358496,"accession":"0001209191-17-063698","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-17-063698","line_url":"/filing/0001209191-17-063698#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1670.0,"shares_display":"1,670","price_per_share":20.5323,"price_display":"20.53","price_state":"stated","total_value":34288.941,"total_display":"34,288.94","total_whole":"34,289","shares_owned_after":14679.0,"shares_owned_after_display":"14,679","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-12-01","filed_date":"2017-12-05","scope":"insider"},{"id":2704342,"accession":"0001209191-16-153410","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-16-153410","line_url":"/filing/0001209191-16-153410#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2429.0,"shares_display":"2,429","price_per_share":20.7415,"price_display":"20.74","price_state":"stated","total_value":50381.1035,"total_display":"50,381.10","total_whole":"50,381","shares_owned_after":11949.0,"shares_owned_after_display":"11,949","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-12-01","filed_date":"2016-12-05","scope":"insider"},{"id":8256025,"accession":"0001209191-15-086771","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-086771","line_url":"/filing/0001209191-15-086771#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7113.0,"shares_display":"7,113","price_per_share":42.0446,"price_display":"42.04","price_state":"stated","total_value":299063.2398,"total_display":"299,063.24","total_whole":"299,063","shares_owned_after":14378.0,"shares_owned_after_display":"14,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-22","filed_date":"2015-12-23","scope":"insider"},{"id":8085303,"accession":"0001209191-15-086363","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-15-086363","line_url":"/filing/0001209191-15-086363#line-2","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":14229.0,"shares_display":"14,229","price_per_share":40.0,"price_display":"40.00","price_state":"stated","total_value":569160.0,"total_display":"569,160.00","total_whole":"569,160","shares_owned_after":14378.0,"shares_owned_after_display":"14,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-17","filed_date":"2015-12-21","scope":"insider"},{"id":8084983,"accession":"0001209191-15-083239","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-15-083239","line_url":"/filing/0001209191-15-083239#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Chief Commercial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Commercial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Commercial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7106.0,"shares_display":"7,106","price_per_share":38.0638,"price_display":"38.06","price_state":"stated","total_value":270481.3628,"total_display":"270,481.36","total_whole":"270,481","shares_owned_after":14378.0,"shares_owned_after_display":"14,378","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-01","filed_date":"2015-12-03","scope":"insider"},{"id":6769679,"accession":"0001209191-14-072921","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-14-072921","line_url":"/filing/0001209191-14-072921#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark":"O","role_mark_label":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP-Commercial Dvlpmnt","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3242.0,"shares_display":"3,242","price_per_share":35.5779,"price_display":"35.58","price_state":"stated","total_value":115343.5518,"total_display":"115,343.55","total_whole":"115,344","shares_owned_after":15161.0,"shares_owned_after_display":"15,161","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-12-01","filed_date":"2014-12-03","scope":"insider"},{"id":5135844,"accession":"0001209191-13-055894","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-055894","line_url":"/filing/0001209191-13-055894#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark":"O","role_mark_label":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP-Commercial Dvlpmnt","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8797.0,"shares_display":"8,797","price_per_share":31.8097,"price_display":"31.81","price_state":"stated","total_value":279829.9309,"total_display":"279,829.93","total_whole":"279,830","shares_owned_after":12403.0,"shares_owned_after_display":"12,403","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-05","filed_date":"2013-12-09","scope":"insider"},{"id":5079295,"accession":"0001209191-13-055279","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-055279","line_url":"/filing/0001209191-13-055279#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark":"O","role_mark_label":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP-Commercial Dvlpmnt","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6603.0,"shares_display":"6,603","price_per_share":33.518,"price_display":"33.52","price_state":"stated","total_value":221319.354,"total_display":"221,319.35","total_whole":"221,319","shares_owned_after":21200.0,"shares_owned_after_display":"21,200","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-12-02","filed_date":"2013-12-04","scope":"insider"},{"id":4793036,"accession":"0001209191-13-054014","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-13-054014","line_url":"/filing/0001209191-13-054014#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark":"O","role_mark_label":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP-Commercial Dvlpmnt","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":10949.0,"shares_display":"10,949","price_per_share":33.7205,"price_display":"33.72","price_state":"stated","total_value":369205.7545,"total_display":"369,205.75","total_whole":"369,206","shares_owned_after":27803.0,"shares_owned_after_display":"27,803","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-11-22","filed_date":"2013-11-25","scope":"insider"},{"id":2412383,"accession":"0001209191-12-055904","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-12-055904","line_url":"/filing/0001209191-12-055904#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark":"O","role_mark_label":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP-Commercial Dvlpmnt","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4364.0,"shares_display":"4,364","price_per_share":24.5782,"price_display":"24.58","price_state":"stated","total_value":107259.2648,"total_display":"107,259.26","total_whole":"107,259","shares_owned_after":31652.0,"shares_owned_after_display":"31,652","ownership_form":"D","is_10b5_1":null,"transaction_date":"2012-12-04","filed_date":"2012-12-05","scope":"insider"},{"id":9056231,"accession":"0001209191-11-059458","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-11-059458","line_url":"/filing/0001209191-11-059458#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark":"O","role_mark_label":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP-Commercial Dvlpmnt","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4364.0,"shares_display":"4,364","price_per_share":22.91,"price_display":"22.91","price_state":"stated","total_value":99979.24,"total_display":"99,979.24","total_whole":"99,979","shares_owned_after":27016.0,"shares_owned_after_display":"27,016","ownership_form":"D","is_10b5_1":null,"transaction_date":"2011-12-01","filed_date":"2011-12-05","scope":"insider"},{"id":7591354,"accession":"0001209191-10-058331","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-10-058331","line_url":"/filing/0001209191-10-058331#line-1","is_derivative":false,"issuer_cik":"0001008848","issuer_name":"ACORDA THERAPEUTICS INC","issuer_ticker":"ACOR","issuer_name_source":null,"issuer_url":"/issuer/0001008848","owner_cik":"0001360928","owner_name":"Sabella Lauren M","owner_display_name":"Sabella Lauren M","owner_url":"/insider/0001360928","role":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark":"O","role_mark_label":"Officer (Exec. VP-Commercial Dvlpmnt)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Exec. VP-Commercial Dvlpmnt","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3933.0,"shares_display":"3,933","price_per_share":26.53,"price_display":"26.53","price_state":"stated","total_value":104342.49,"total_display":"104,342.49","total_whole":"104,342","shares_owned_after":21067.0,"shares_owned_after_display":"21,067","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-12-01","filed_date":"2010-12-03","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":20,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":20,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":20},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001008848","name":"ACORDA THERAPEUTICS INC","url":"/issuer/0001008848","role":"Officer (Chief Commercial Officer)","n_filings":19,"first_seen":"2010-12-03","last_seen":"2019-12-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001360928","retrieved_at":"2026-08-23T07:18:13+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}